Speaking to CNBC-TV18, Habil Khorakiwala, founder, chairman and CEO of Wockhardt said that due to demonetisation and the translational loss in pound due to Brexit lead to weak earnings this quarter. Money Control, 1 month ago
3 images for "habil khorakiwala"
Wockhardt chief Habil Khorakiwala says that Indian generic company as a whole is a competitive industry in US and therefore there is no scope for government intervention there. Anmol Ganjoo of JM Financial says if drug prices come down then Indian pharma ...Money Control, 1 month ago
The pharmaceutical industry did suffer some set back with sales declining about 10-12 percent since demonetisation. However, Habil F Khorakiwala, Founder, Chairman Group CEO of Wockhardt feels the impact will last only until January at the most as cash ...Money Control, 2 months ago
on your WebpageAdd Widget >Get your members hooked!